Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
Phase 2
Completed
- Conditions
- Social Anxiety Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- EmpowerPharm Inc.
- Target Recruit Count
- 239
- Registration Number
- NCT05600114
- Locations
- 🇺🇸
EPI-CBD-001 Site, Bellevue, Washington, United States
🇺🇸EPI-CBD-001-Site, Rochester, New York, United States
🇺🇸EPI-CBD-001 site, Wichita Falls, Texas, United States
News
No news found